nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—HTR6—Serotonin receptors—HTR2A—narcolepsy	0.0352	0.0362	CbGpPWpGaD
Raloxifene—HTR2B—Serotonin receptors—HTR2A—narcolepsy	0.0322	0.033	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—SOCS2—narcolepsy	0.029	0.0298	CbGpPWpGaD
Raloxifene—HTR6—Amine ligand-binding receptors—HRH3—narcolepsy	0.0265	0.0272	CbGpPWpGaD
Raloxifene—HTR2B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0241	0.0248	CbGpPWpGaD
Raloxifene—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—narcolepsy	0.0214	0.022	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0199	0.0204	CbGpPWpGaD
Raloxifene—HTR6—G alpha (s) signalling events—P2RY11—narcolepsy	0.0193	0.0198	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—PENK—narcolepsy	0.0176	0.0181	CbGpPWpGaD
Raloxifene—HTR6—Monoamine GPCRs—HTR2A—narcolepsy	0.0157	0.0161	CbGpPWpGaD
Raloxifene—HTR2B—Monoamine GPCRs—HTR2A—narcolepsy	0.0143	0.0147	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.0135	0.0139	CbGpPWpGaD
Raloxifene—HTR6—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0132	0.0135	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0131	0.0135	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0131	0.0135	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—P2RY11—narcolepsy	0.0127	0.013	CbGpPWpGaD
Raloxifene—HTR2B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.012	0.0124	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0118	0.0121	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0118	0.0121	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0114	0.0117	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.0113	0.0117	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0111	0.0114	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0111	0.0114	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—HCRT—narcolepsy	0.0108	0.0111	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0107	0.011	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0102	0.0104	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0102	0.0104	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00981	0.0101	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00965	0.00992	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00954	0.0098	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00954	0.0098	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00921	0.00946	CbGpPWpGaD
Raloxifene—HTR6—G alpha (s) signalling events—NPS—narcolepsy	0.00904	0.00929	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CHKB—narcolepsy	0.00886	0.00911	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0087	0.00894	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0087	0.00894	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00841	0.00864	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—TRH—narcolepsy	0.00818	0.0084	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00783	0.00805	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00732	0.00752	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HCRTR2—narcolepsy	0.00726	0.00746	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HCRTR1—narcolepsy	0.00726	0.00746	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00715	0.00734	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—P2RY11—narcolepsy	0.00701	0.00721	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00698	0.00717	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00683	0.00701	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HCRTR1—narcolepsy	0.00663	0.00681	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HCRTR2—narcolepsy	0.00663	0.00681	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—CTNNBL1—narcolepsy	0.00651	0.00668	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—P2RY11—narcolepsy	0.0064	0.00658	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00637	0.00655	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00607	0.00624	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CPT1B—narcolepsy	0.00602	0.00619	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HCRT—narcolepsy	0.00596	0.00613	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—NPS—narcolepsy	0.00594	0.00611	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—TAC1—narcolepsy	0.00594	0.00611	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00593	0.0061	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0057	0.00586	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00554	0.0057	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HCRT—narcolepsy	0.00544	0.00559	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00542	0.00557	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00532	0.00546	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00532	0.00546	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—PENK—narcolepsy	0.00531	0.00546	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0052	0.00535	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CHKB—narcolepsy	0.00491	0.00505	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—PENK—narcolepsy	0.00485	0.00498	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00475	0.00488	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—TRH—narcolepsy	0.00452	0.00464	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00431	0.00443	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00431	0.00443	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—TRH—narcolepsy	0.00412	0.00424	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HCRTR2—narcolepsy	0.0041	0.00422	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HCRTR1—narcolepsy	0.0041	0.00422	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—P2RY11—narcolepsy	0.00396	0.00407	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—HRH3—narcolepsy	0.00396	0.00407	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00394	0.00404	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00394	0.00404	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00393	0.00404	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00388	0.00398	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00375	0.00385	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00375	0.00385	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HCRTR2—narcolepsy	0.00373	0.00383	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HCRTR1—narcolepsy	0.00373	0.00383	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00362	0.00372	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HRH3—narcolepsy	0.00362	0.00372	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—P2RY11—narcolepsy	0.0036	0.0037	CbGpPWpGaD
Raloxifene—HTR6—forebrain—narcolepsy	0.00359	0.134	CbGeAlD
Raloxifene—HTR2B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00358	0.00367	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HCRTR2—narcolepsy	0.0034	0.00349	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HCRTR1—narcolepsy	0.0034	0.00349	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HCRT—narcolepsy	0.00337	0.00346	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CPT1B—narcolepsy	0.00334	0.00343	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—P2RY11—narcolepsy	0.00329	0.00338	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—NPS—narcolepsy	0.00328	0.00337	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—TAC1—narcolepsy	0.00328	0.00337	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—CTNNBL1—narcolepsy	0.00328	0.00337	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0032	0.00329	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0031	0.00319	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HCRT—narcolepsy	0.00308	0.00316	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HCRT—narcolepsy	0.00306	0.00314	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00303	0.00311	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PENK—narcolepsy	0.003	0.00309	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—TAC1—narcolepsy	0.003	0.00308	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—NPS—narcolepsy	0.003	0.00308	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00294	0.00302	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HCRT—narcolepsy	0.00279	0.00287	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00276	0.00284	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PENK—narcolepsy	0.00274	0.00282	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PENK—narcolepsy	0.00273	0.0028	CbGpPWpGaD
Raloxifene—ESR2—brainstem—narcolepsy	0.00261	0.0978	CbGeAlD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00259	0.00267	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TRH—narcolepsy	0.00255	0.00262	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CHKB—narcolepsy	0.00254	0.00261	CbGpPWpGaD
Raloxifene—ESR2—forebrain—narcolepsy	0.00252	0.0944	CbGeAlD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.0025	0.00257	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.00249	0.00256	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00237	0.00243	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.00233	0.0024	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TRH—narcolepsy	0.00232	0.00238	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HRH3—narcolepsy	0.00224	0.0023	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HCRTR1—narcolepsy	0.0022	0.00226	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HCRTR2—narcolepsy	0.0022	0.00226	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—P2RY11—narcolepsy	0.00213	0.00218	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.00212	0.00217	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00211	0.00217	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.00204	0.0021	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRH3—narcolepsy	0.00203	0.00209	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.00201	0.00206	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.00201	0.00206	CbGpPWpGaD
Raloxifene—CYP19A1—forebrain—narcolepsy	0.00199	0.0744	CbGeAlD
Raloxifene—HTR6—GPCR ligand binding—HTR2A—narcolepsy	0.00198	0.00203	CbGpPWpGaD
Raloxifene—HTR2B—forebrain—narcolepsy	0.00195	0.073	CbGeAlD
Raloxifene—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.00194	0.00199	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.00186	0.00191	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TAC1—narcolepsy	0.00186	0.00191	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—NPS—narcolepsy	0.00186	0.00191	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HCRT—narcolepsy	0.00181	0.00186	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.0018	0.00185	CbGpPWpGaD
Raloxifene—ESR1—brainstem—narcolepsy	0.00179	0.067	CbGeAlD
Raloxifene—ESR1—forebrain—narcolepsy	0.00173	0.0647	CbGeAlD
Raloxifene—CYP19A1—Metabolism—CPT1B—narcolepsy	0.00173	0.00177	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.00169	0.00174	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.00169	0.00174	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—NPS—narcolepsy	0.00168	0.00173	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TAC1—narcolepsy	0.00168	0.00173	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HCRTR2—narcolepsy	0.00167	0.00172	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HCRTR1—narcolepsy	0.00167	0.00172	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HCRT—narcolepsy	0.00165	0.0017	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CHKB—narcolepsy	0.00163	0.00168	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—P2RY11—narcolepsy	0.00162	0.00166	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PENK—narcolepsy	0.00161	0.00166	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—NPS—narcolepsy	0.00154	0.00158	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TAC1—narcolepsy	0.00154	0.00158	CbGpPWpGaD
Raloxifene—HTR6—brain—narcolepsy	0.00149	0.0558	CbGeAlD
Raloxifene—HTR2B—Signaling Pathways—PENK—narcolepsy	0.00147	0.00151	CbGpPWpGaD
Raloxifene—SIGMAR1—medulla oblongata—narcolepsy	0.00141	0.0529	CbGeAlD
Raloxifene—CYP2C8—Metabolism—CHKB—narcolepsy	0.00138	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HCRT—narcolepsy	0.00137	0.00141	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TRH—narcolepsy	0.00137	0.00141	CbGpPWpGaD
Raloxifene—SIGMAR1—midbrain—narcolepsy	0.00129	0.0483	CbGeAlD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.00126	0.00129	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TRH—narcolepsy	0.00125	0.00128	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PENK—narcolepsy	0.00123	0.00126	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRH3—narcolepsy	0.0012	0.00123	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2A—narcolepsy	0.00112	0.00115	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CPT1B—narcolepsy	0.00111	0.00114	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRH3—narcolepsy	0.0011	0.00113	CbGpPWpGaD
Raloxifene—ESR2—brain—narcolepsy	0.00105	0.0392	CbGeAlD
Raloxifene—ESR1—Signaling Pathways—TRH—narcolepsy	0.00104	0.00107	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	0.00102	0.00105	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2A—narcolepsy	0.00101	0.00104	CbGpPWpGaD
Raloxifene—AOX1—brain—narcolepsy	0.00101	0.0377	CbGeAlD
Raloxifene—HTR6—Signaling Pathways—NPS—narcolepsy	0.000995	0.00102	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TAC1—narcolepsy	0.000995	0.00102	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000939	0.000964	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	0.000925	0.000951	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRH3—narcolepsy	0.000913	0.000938	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NPS—narcolepsy	0.000909	0.000934	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TAC1—narcolepsy	0.000909	0.000934	CbGpPWpGaD
Raloxifene—CYP19A1—brain—narcolepsy	0.000824	0.0309	CbGeAlD
Raloxifene—SIGMAR1—brain—narcolepsy	0.000811	0.0304	CbGeAlD
Raloxifene—HTR2B—brain—narcolepsy	0.000809	0.0303	CbGeAlD
Raloxifene—ESR1—Signaling Pathways—TAC1—narcolepsy	0.000757	0.000778	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NPS—narcolepsy	0.000757	0.000778	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CHKB—narcolepsy	0.000741	0.000761	CbGpPWpGaD
Raloxifene—ESR1—brain—narcolepsy	0.000717	0.0268	CbGeAlD
Raloxifene—HTR6—Signaling Pathways—HTR2A—narcolepsy	0.000599	0.000615	CbGpPWpGaD
Raloxifene—CYP2C8—brain—narcolepsy	0.00059	0.0221	CbGeAlD
Raloxifene—HTR2B—Signaling Pathways—HTR2A—narcolepsy	0.000547	0.000562	CbGpPWpGaD
Raloxifene—CYP2B6—brain—narcolepsy	0.000529	0.0198	CbGeAlD
Raloxifene—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000504	0.000518	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—narcolepsy	0.000455	0.000468	CbGpPWpGaD
